title: Oral sildenafil in skin ulcers secondary to systemic sclerosis.
authors.forename: A
authors.initials: A
authors.lastname: Della Rossa
authors.forename: M
authors.initials: M
authors.lastname: Doveri
authors.forename: A
authors.initials: A
authors.lastname: D'Ascanio
authors.forename: A
authors.initials: A
authors.lastname: Tavoni
authors.forename: A
authors.initials: A
authors.lastname: Consensi
authors.forename: R
authors.initials: R
authors.lastname: Neri
authors.forename: L
authors.initials: L
authors.lastname: Bazzichi
authors.forename: S
authors.initials: S
authors.lastname: Bombardieri
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004305:Dose-Response Relationship, Drug; D005260:Female; D005385:Fingers; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011687:Purines / Q000008:administration & dosage / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000150:complications*; D000068677:Sildenafil Citrate; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology*; D013450:Sulfones / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate